Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Atnahs Pharma UK Ltd., Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, UK
Synacthen Depot Ampoules 1mg/ml.
| Pharmaceutical Form |
|---|
|
Suspension for injection. Tetracosactide acetate is absorbed on to zinc phosphate. A sterile, milky white suspension, which settles on standing, in a clear glass ampoule. |
Tetracosactide acetate 1mg/ml.
Excipient(s) with known effect:
Contains benzyl alcohol (10mg/ml).
Each ampoule contains a total of 3.32 mg of sodium.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tetracosactide |
Tetracosactide acetate consists of the first 24 amino acids occurring in the natural corticotropic hormone (ACTH) sequence and displays the same physiological properties as ACTH. In the adrenal cortex, it stimulates the biosynthesis of glucocorticoids, mineralocorticoids, and, to a lesser extent, androgens, which explains its therapeutic effect in conditions responsive to glucocorticoid treatment. |
| List of Excipients |
|---|
|
Zinc chloride anhydrous pure |
Synacthen Depot comes in cardboard boxes of 1 ampoule and 10 ampoules.
Not all pack sizes may be marketed.
Atnahs Pharma UK Ltd., Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, UK
PL 43252/0027
25 June 1998
| Drug | Countries | |
|---|---|---|
| SYNACTHEN | Australia, Estonia, Ireland, Lithuania, Malta, Netherlands, New Zealand, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
